Sign Up for Programmes and Events Updates
Four international awardees of HKU Scholarship for Future Leaders pursue dreams at HKU
The University of Hong Kong (HKU) established the HKU Scholarship for Future Leaders in the 2019/20 academic year to support talented students from developing countries to pursue their dreams at HKU. Applications were received from students in Ghana, Madagascar, Nepal, Nigeria and Turkey. Although face-to-face classes have been moved online due to the COVID-19 pandemic, our students turned a new page at HKU by actively participating in virtual classes.
HKU State Key Laboratory for Emerging Infectious Diseases co-developed COVID-19 vaccine candidate approved for clinical trial in humans
The State Key Laboratory for Emerging Infectious Diseases of the University of Hong Kong (the SKL) has partnered with Xiamen University and Wantai Biopharmaceutical company to rapidly develop a vaccine candidate against COVID-19.
Memory in a metal, enabled by quantum geometry Breakthrough made by Professor Xiang Zhang’s research team
The emergence of artificial intelligence and machine learning techniques is changing the world dramatically with novel applications such as internet of things, autonomous vehicles, real-time imaging processing and big data analytics in healthcare. In 2020, the global data volume is estimated to reach 44 Zettabytes, and it will continue to grow beyond the current capacity of computing and storage devices. At the same time, the related electricity consumption will increase 15 times by 2030, swallowing 8% of the global energy demand. Therefore, reducing energy consumption and increasing speed of...
HKUMed unveils the novel function of extracellular vesicle in driving liver cancer metastasis, providing new targets for early diagnosis and treatment
A research team at LKS Faculty of Medicine, The University of Hong Kong (HKUMed) discovered that tumour-derived extracellular vesicles promote liver cancer metastasis. The novel findings of the tumour-derived extracellular vesicles provide insights into promising biomarker and new therapeutic approach for liver cancer. The ground-breaking findings have been published in the leading multidisciplinary science journal, Advanced Science.
HKUMed researchers discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response and can be used for more specific testing of COVID-19 infection
Researchers from HKU-Pasteur Research Pole at the School of Public Health, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) used Luciferase Immunoprecipitation System (LIPS) assay and discovered that ORF8 and ORF3b are major targets of SARS-CoV-2 humoral immune response and can be used for more specific testing of COVID-19 infection. The study is the first among research teams worldwide to determine the most comprehensive “landscape” of antibody responses to SARS-CoV-2. The ground-breaking findings on COVID-19 serology are now published in Nature Immunology, a leading...